Prenetics Global Limited

NasdaqGM:PRE Rapporto sulle azioni

Cap. di mercato: US$54.0m

Prenetics Global Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Danny Yeung

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO12.9%
Durata media del management1.8yrs
Durata media del Consiglio di amministrazione1.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors

Oct 12
Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors

Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump

May 29
Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump

Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues

Apr 08
Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues

Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Jan 07
Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M

Sep 09

AMMINISTRATORE DELEGATO

Danny Yeung (45 yo)

no data

Mandato

Mr. Sheng Wu Yeung, also known as Danny, serves as Co-Founder, Chairperson & Chief Executive Officer at Prenetics Global Limited. He served as Founding Partner at SXE Ventures. Mr. Yeung is a serial entrep...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Sheng Wu Yeung
Co-Founderno dataNessun dato12.94%
$ 7.0m
Chi Hung Tzang
Co-Founder & Chief Scientific Officer10.8yrsNessun dato4.4%
$ 2.4m
Hoi Chun Lo
Chief Financial Officer6.8yrsNessun dato1.33%
$ 718.8k
Samantha Kwok
Chief of Staff to Group CEO & Vice President of People & Operations1.8yrsNessun datoNessun dato
Yung Ho Wong
Chief Technology Officerno dataNessun datoNessun dato
Senthil Sundaram
Chief Clinical Officerno dataNessun datoNessun dato
Joel Neoh
Chief Consumer Officer & CEO for CircleDNA1.4yrsNessun datoNessun dato
Walt Ling
Chief Executive Officer of ACT Genomics1.8yrsNessun datoNessun dato

1.8yrs

Durata media

43.5yo

Età media

Gestione esperta: Il team dirigenziale di PRE non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Sheng Wu Yeung
Co-Founderno dataNessun dato12.94%
$ 7.0m
Pasi Antero Janne
Member of Scientific Advisory Board1.7yrsNessun datoNessun dato
Kathryn Henry
Independent Directorless than a yearNessun datoNessun dato
Wing Kwan Chiu
Independent Directorno dataNessun datoNessun dato
David L. Katz
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
Shu Kam Mok
Chairman of Scientific Advisory Board1.7yrsNessun datoNessun dato
Yin Pan Cheng
Independent Directorno dataNessun datoNessun dato
David Vanderveen
Independent Directorless than a yearNessun datoNessun dato
Suzanne Devkota
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
Pan-Chyr Yang
Member of Scientific Advisory Board1.7yrsNessun datoNessun dato
James L. Green
Member of Scientific Advisory Boardless than a yearNessun datoNessun dato
Dawn Mussallem
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato

1.2yrs

Durata media

55yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di PRE non è considerato esperto (durata media del mandato 1.2 anni), il che suggerisce un nuovo consiglio.